STAAR SurgicalSTAA
About: Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Employees: 1,115
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
95% more call options, than puts
Call options by funds: $17.7M | Put options by funds: $9.05M
48% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 31
20% more funds holding in top 10
Funds holding in top 10: 5 [Q2] → 6 (+1) [Q3]
7% more funds holding
Funds holding: 216 [Q2] → 231 (+15) [Q3]
0.07% less ownership
Funds ownership: 97.48% [Q2] → 97.41% (-0.07%) [Q3]
9% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 79
22% less capital invested
Capital invested by funds: $2.28B [Q2] → $1.78B (-$500M) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Canaccord Genuity Jon Young 67% 1-year accuracy 4 / 6 met price target | 19%upside $31 | Hold Maintained | 1 Nov 2024 |
Stifel Thomas Stephan 50% 1-year accuracy 5 / 10 met price target | 68%upside $44 | Buy Maintained | 26 Aug 2024 |
Financial journalist opinion
Based on 7 articles about STAA published over the past 30 days
